KPIs & Operating Metrics(New)
Growth Metrics

Teva Pharmaceutical Industries (TEVA) Net Income - Minority (2016 - 2025)

Historic Net Income - Minority for Teva Pharmaceutical Industries (TEVA) over the last 17 years, with Q4 2025 value amounting to -$4.0 million.

  • Teva Pharmaceutical Industries' Net Income - Minority rose 4285.71% to -$4.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$4.0 million, marking a year-over-year increase of 4285.71%. This contributed to the annual value of -$4.0 million for FY2025, which is 4285.71% up from last year.
  • According to the latest figures from Q4 2025, Teva Pharmaceutical Industries' Net Income - Minority is -$4.0 million, which was up 4285.71% from -$4.0 million recorded in Q3 2025.
  • In the past 5 years, Teva Pharmaceutical Industries' Net Income - Minority registered a high of -$4.0 million during Q3 2025, and its lowest value of -$987.0 million during Q2 2021.
  • Moreover, its 5-year median value for Net Income - Minority was -$638.0 million (2023), whereas its average is -$529.5 million.
  • As far as peak fluctuations go, Teva Pharmaceutical Industries' Net Income - Minority plummeted by 154.32% in 2021, and later soared by 9887.1% in 2024.
  • Over the past 5 years, Teva Pharmaceutical Industries' Net Income - Minority (Quarter) stood at -$966.0 million in 2021, then rose by 17.81% to -$794.0 million in 2022, then rose by 21.91% to -$620.0 million in 2023, then soared by 98.87% to -$7.0 million in 2024, then skyrocketed by 42.86% to -$4.0 million in 2025.
  • Its Net Income - Minority stands at -$4.0 million for Q4 2025, versus -$4.0 million for Q3 2025 and -$7.0 million for Q2 2025.